Related Experiment Video
Updated: Aug 20, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Melanoma classification and management in the era of molecular medicine
Sarem Rashid1, Michael Shaughnessy2, Hensin Tsao3
1Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Boston University School of Medicine, Boston, MA 02118, USA.
Abstract:
Melanoma is the most lethal form of skin cancer although surgery is often curative when combined with early screening and prevention. In recurrent or advanced cancer, the emergence of chemotherapy, targeted therapy, and immune checkpoint inhibitors has demonstrated promising clinical outcomes. Such approaches can remarkably halt the progression of disease for many years, although are limited by the acquisition of resistance. The development and approval of combination therapies has further changed the treatment paradigm for certain melanomas. This review focuses on the current state of melanoma epidemiology and recent advancements in melanoma screening, histopathological classification, staged excision (i.e. wide local excision, sentinel lymph node biopsy, and Mohs micrographic surgery), and systemic treatment.
Insights
This review covers melanoma epidemiology and advances in screening, diagnosis, and treatment. It highlights how new therapies offer hope but face challenges like drug resistance.
Area of Science:
- Dermatology
- Oncology
- Cancer Research
Background:
- Melanoma is a lethal skin cancer, but early detection and treatment improve outcomes.
- Advanced melanoma treatments like chemotherapy and immunotherapy show promise but face resistance.
- Combination therapies are transforming melanoma treatment paradigms.
Purpose of the Study:
- To review current melanoma epidemiology.
- To discuss recent advancements in melanoma screening and diagnosis.
- To summarize updated surgical and systemic treatment strategies.
Main Methods:
- Literature review of melanoma epidemiology.
- Analysis of recent advancements in screening and histopathological classification.
- Review of staged excision techniques (wide local excision, sentinel lymph node biopsy, Mohs surgery).
- Evaluation of current systemic treatments including chemotherapy, targeted therapy, and immunotherapy.
Main Results:
- Melanoma incidence and mortality rates.
- Effectiveness of early screening and prevention strategies.
- Clinical outcomes and limitations of current systemic therapies.
- Impact of combination therapies on melanoma treatment.
Conclusions:
- Early detection and prevention remain crucial for melanoma management.
- Systemic therapies have improved outcomes but resistance is a significant challenge.
- Ongoing research into novel treatments and combination therapies is vital for advancing melanoma care.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy
Cancer

